Pluristem Therapeutics (PSTI) Releases Quarterly Earnings Results, Hits Estimates
Pluristem Therapeutics (NASDAQ:PSTI) released its earnings data on Thursday. The company reported ($0.14) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.14), Analyst Ratings.Net reports.
Shares of Pluristem Therapeutics (NASDAQ:PSTI) opened at 3.44 on Thursday. Pluristem Therapeutics has a 52 week low of $2.47 and a 52 week high of $4.63. The stock has a 50-day moving average of $3.56 and a 200-day moving average of $3.68. The company’s market cap is $233.6 million.
Pluristem Therapeutics Inc (NASDAQ:PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.